TC BioPharm (Holdings) PLC (TCBP)
1.06
-0.02
(-1.85%)
USD |
NASDAQ |
Jun 10, 16:00
1.07
+0.01
(+0.94%)
After-Hours: 20:00
TC BioPharm Cash from Operations (Quarterly): -3.055M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.055M |
June 30, 2023 | -4.662M |
March 31, 2023 | -3.539M |
Date | Value |
---|---|
September 30, 2021 | -4.183M |
September 30, 2020 | -2.469M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.662M
Minimum
Jun 2023
-2.469M
Maximum
Sep 2020
-3.582M
Average
-3.539M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | -31.95M |
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | -7.462M |
Autolus Therapeutics PLC | -40.51M |
Verona Pharma PLC | -13.61M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.0071M |
Cash from Financing (Quarterly) | 1.183M |
Free Cash Flow | -15.84M |
Free Cash Flow Per Share (Quarterly) | -2.032 |
Free Cash Flow Yield | -3.19K% |